These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 5577970)

  • 41. Understanding the relevance of herb-drug interaction studies with special focus on interplays: a prerequisite for integrative medicine.
    Borse SP; Singh DP; Nivsarkar M
    Porto Biomed J; 2019; 4(2):e15. PubMed ID: 31595257
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prediction of Tissue-Plasma Partition Coefficients Using Microsomal Partitioning: Incorporation into Physiologically based Pharmacokinetic Models and Steady-State Volume of Distribution Predictions.
    Holt K; Ye M; Nagar S; Korzekwa K
    Drug Metab Dispos; 2019 Oct; 47(10):1050-1060. PubMed ID: 31324699
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Membrane Cholesterol Modulates Superwarfarin Toxicity.
    Marangoni MN; Martynowycz MW; Kuzmenko I; Braun D; Polak PE; Weinberg G; Rubinstein I; Gidalevitz D; Feinstein DL
    Biophys J; 2016 Apr; 110(8):1777-1788. PubMed ID: 27119638
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations.
    Palareti G; Legnani C
    Clin Pharmacokinet; 1996 Apr; 30(4):300-13. PubMed ID: 8983860
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stereoselective interaction of phenylbutazone with [12C/13C]warfarin pseudoracemates in man.
    O'Reilly RA; Trager WF; Motley CH; Howald W
    J Clin Invest; 1980 Mar; 65(3):746-53. PubMed ID: 7354137
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aminoglutethimide and warfarin. A new important drug interaction.
    Lønning PE; Kvinnsland S; Jahren G
    Cancer Chemother Pharmacol; 1984; 12(1):10-2. PubMed ID: 6690067
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug interactions with warfarin.
    Serlin MJ; Breckenridge AM
    Drugs; 1983 Jun; 25(6):610-20. PubMed ID: 6347619
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The influence of a graded dose schedule of aminoglutethimide on the disposition of the optical enantiomers of warfarin in patients with breast cancer.
    Lønning PE; Ueland PM; Kvinnsland S
    Cancer Chemother Pharmacol; 1986; 17(2):177-81. PubMed ID: 3719899
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship.
    Holford NH
    Clin Pharmacokinet; 1986; 11(6):483-504. PubMed ID: 3542339
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetic data. Pharmacokinetic parameters estimated from intravenous data by uniform methods and some of their uses.
    Wagner JG
    J Pharmacokinet Biopharm; 1977 Apr; 5(2):161-82. PubMed ID: 859101
    [No Abstract]   [Full Text] [Related]  

  • 51. Clinical pharmacokinetics of oral anticoagulants.
    Kelly JG; O'Malley K
    Clin Pharmacokinet; 1979; 4(1):1-15. PubMed ID: 369763
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protein binding of coumarin anticoagulants in disease states.
    Bachmann K; Shapiro R
    Clin Pharmacokinet; 1977; 2(2):110-26. PubMed ID: 324687
    [No Abstract]   [Full Text] [Related]  

  • 53. Protein binding and kinetics of drugs in liver diseases.
    Blaschke TF
    Clin Pharmacokinet; 1977; 2(1):32-44. PubMed ID: 322909
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A model solution for intestinal absorption of warfarin. A drug with non-linear distribution pharmacokinetics in the rat.
    Julkunen RJ; Kekki M; Wahlström B
    Arzneimittelforschung; 1980; 30(2):264-7. PubMed ID: 7378103
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Warfarin pharmacokinetics in the horse.
    Thijssen HH; van den Bogaard AE; Wetzel JM; Maes JH; Muller AP
    Am J Vet Res; 1983 Jul; 44(7):1192-6. PubMed ID: 6881659
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of microdosing to predict pharmacokinetics at the therapeutic dose: experience with 5 drugs.
    Lappin G; Kuhnz W; Jochemsen R; Kneer J; Chaudhary A; Oosterhuis B; Drijfhout WJ; Rowland M; Garner RC
    Clin Pharmacol Ther; 2006 Sep; 80(3):203-15. PubMed ID: 16952487
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of warfarin following intravenous administration to man.
    O'Reilly RA; Welling PG; Wagner JG
    Thromb Diath Haemorrh; 1971; 25(1):178-86. PubMed ID: 5577970
    [No Abstract]   [Full Text] [Related]  

  • 58. Comparison of plasma levels of antipyrine, tolbutamide, and warfarin after oral and intravenous administration.
    Andreasen PB; Vesell ES
    Clin Pharmacol Ther; 1974 Dec; 16(6):1059-65. PubMed ID: 4611464
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.